After FDA published the final “Guidance for Industry on electronic submission” that will require submission data in CDISC standards, all the life sciences organizations focus on implementing CDISC standards on clinical data development. However, organizations also see other opportunities with CDISC standards. The presentation will introduce what could be possible through Standards such as Standards-driven automated process in clinical artefacts development and how the organization need to manage and govern standards in order to achieve the next steps.